Multiple Myeloma in Relapse Terminated Phase 1 Trials for Pomalidomide (DB08910)

IndicationStatusPhase
DBCOND0036092 (Multiple Myeloma in Relapse)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01889420Phase I Trial of Everolimus, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple MyelomaTreatment